| Title |
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, January 2019
|
| DOI | 10.1007/s10549-018-05086-8 |
| Pubmed ID | |
| Authors |
Xiaoqing Xu, Rowan T. Chlebowski, Jiaxiao Shi, Ana Barac, Reina Haque |
X Demographics
The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 13% |
| United Kingdom | 2 | 13% |
| Netherlands | 1 | 6% |
| France | 1 | 6% |
| Australia | 1 | 6% |
| Mexico | 1 | 6% |
| Unknown | 8 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 44% |
| Practitioners (doctors, other healthcare professionals) | 6 | 38% |
| Scientists | 3 | 19% |
Mendeley readers
The data shown below were compiled from readership statistics for 53 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 53 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 7 | 13% |
| Student > Bachelor | 6 | 11% |
| Other | 4 | 8% |
| Researcher | 4 | 8% |
| Student > Ph. D. Student | 4 | 8% |
| Other | 5 | 9% |
| Unknown | 23 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 30% |
| Biochemistry, Genetics and Molecular Biology | 4 | 8% |
| Nursing and Health Professions | 2 | 4% |
| Unspecified | 1 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 27 | 51% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#3,253,909
of 24,960,237 outputs
Outputs from Breast Cancer Research and Treatment
#484
of 4,930 outputs
Outputs of similar age
#72,784
of 448,829 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#5
of 65 outputs
Altmetric has tracked 24,960,237 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,930 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 448,829 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.